Text of Senate Amendment 374

Text of Senate Amendment 374

Congressional Record, Volume 171 Issue 34 (Thursday, February 20, 2025) [Congressional Record Volume 171, Number 34 (Thursday, February 20, 2025)] [Senate] [Page S1184] From the Congressional Record Online through the Government Publishing Office [ www.gpo.gov ] SA 374. Ms. CORTEZ MASTO (for herself, Ms. Alsobrooks, and Mr. Kim) submitted an amendment intended to be proposed by her to the concurrent resolution S. Con. Res. 7, setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; which was ordered to lie on the table; as follows: At the end of title III, add the following: SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO LOWERING PRESCRIPTION DRUG PRICES. The Chairman of the Committee on the Budget of the Senate may revise the allocations of a committee or committees, aggregates, and other appropriate levels in this resolution, and make adjustments to the pay-as-you-go ledger, for one or more bills, joint resolutions, amendments, amendments between the Houses, motions, or conference reports relating to lowering prescription drug prices, which may include imposing monetary penalties on drug manufacturers with respect to prescription drug sales in the commercial market if the average price of such drugs increases faster than the rate of inflation or implementing other policies that penalize drug manufacturers for increasing drug prices faster than inflation, by the amounts provided in such legislation for those purposes, provided that such legislation would not increase the deficit over the period of the total of fiscal years 2025 through 2034. ______